Meta-Analysis of the Use of Rescue Antiemetics Following PONV Prophylactic Failure with 5-HT3 Antagonist/Dexamethasone Versus Single-Agent Therapies

@article{Kovac2006MetaAnalysisOT,
  title={Meta-Analysis of the Use of Rescue Antiemetics Following PONV Prophylactic Failure with 5-HT3 Antagonist/Dexamethasone Versus Single-Agent Therapies},
  author={Anthony L. Kovac},
  journal={Annals of Pharmacotherapy},
  year={2006},
  volume={40},
  pages={873 - 887}
}
  • A. Kovac
  • Published 1 May 2006
  • Medicine
  • Annals of Pharmacotherapy
Objective: To assess the use of rescue antiemetic medication following 5-HT3 receptor antagonist (5-HT3RA) plus dexamethasone therapy versus monotherapy with a 5-HT3RA for prophylaxis of postoperative nausea and vomiting (PONV). Data Sources: Reports of randomized, controlled trials were identified via a MEDLINE search (1966–September 2005) using the key terms ondansetron, dolasetron, tropisetron, granisetron, 5-HT3, PONV, vomiting, emesis, and nausea. Study Selection and Data Extraction… 

Tables from this paper

Effects of aprepitant /dexamethasone versus mirtazapine/dexamethasone on postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a randomized controlled trial
TLDR
A/D and M/D combinations were superior to D alone regarding the proportion of patients exhibiting a complete response in preventing PONV associated with LSG and the patient’s satisfaction score.
Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable?
TLDR
A “zero-tolerance” antiemetic algorithm for outpatients that involves routine prophylaxis by first avoiding volatile agents and opioids to the extent possible, using locoregional anesthesia, multimodal analgesia, and low doses of three nonsedating off-patent antiemetics is proposed.
Randomized Double Blind Comparative Study Comparing Efficacy of Granisetron and Ondansetron for the Prophylactic Control of Postoperative Nausea and Vomiting in Patients Undergoing Middle Ear Surgery
TLDR
Grisetron is more efficacious and desirable drug than ondansetron for reducing the incidence of PONV in patients undergoing middle ear surgery and willingness to have the same prophylactic antiemetic drug in future was significantly high in patients receiving granisetron.
A Randomized Controlled Trial for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy: Aprepitant/Dexamethasone vs. Mirtazapine/Dexamethasone
TLDR
Aprepitant/dexamethasone combination and mirtazapine/dExamethAsone combination were superior to dexameth asone alone in alleviating postoperative nausea and vomiting in morbidly obese patients scheduled to undergo laparoscopic sleeve gastrectomy.
Mechanisms Underlying Postoperative Nausea and Vomiting and Neurotransmitter Receptor Antagonist-Based Pharmacotherapy
  • T. Gan
  • Medicine, Biology
    CNS drugs
  • 2007
TLDR
NK1 receptor antagonists, with their unique mechanism of action, are a particularly promising area of research as they appear to be efficacious in preventing PONV during both the early and the late postoperative periods.
Current research on PONV/PDNV: Practical implications for today's pharmacist.
  • R. Ignoffo
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2009
TLDR
Evidence from the Prospective Observational Study of Treatments, Outcomes, and Patterns of Care study indicates that the use of guideline recommended PONV and PDNV prophylactic treatments leads to improved outcomes.
Propofol for the management of postoperative nausea and vomiting (PONV)
TLDR
The main objective of these series of investigations was to systematically determine the antiemetic effects of propofol and recommend how prop ofol should be used in clinical practice.
Aprepitant vs. Multimodal Prophylaxis in the Prevention of Nausea and Vomiting following Extended‐Release Epidural Morphine
TLDR
The incidence of PONV following prophylactic aprepitant, a neurokinin‐1 antagonist, was compared with proPHylactic multimodal antiemetic therapy in patients receiving EREM for postoperative analgesia following unilateral primary total knee arthroplasty.
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
TLDR
DDIs can play significant roles in drugs’ cardiac safety, as evidenced by the provided examples, and PD components of DDIs should be accounted for as PK changes alone do not allow to fully explain the electrophysiological effects in clinic situations.
Design and Implementation of an Enhanced Recovery After Surgery (ERAS) Protocol in Elective Lumbar Spine Fusion by Posterior Approach: A Retrospective, Comparative Study.
TLDR
Implementation of an ERAS protocol is feasible for elective lumbar spine fusion, and leads to shorter LOS and improved early pain and functional outcome scores, and was not significant at intermediate term follow up.
...
...

References

SHOWING 1-10 OF 148 REFERENCES
The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials
TLDR
It is concluded that there is no statistically significant difference in antiemetic efficacy or side effects profile when one of the 5-HT is combined with either droperidol or dexamethasone and that both combination regimens are significantly more effective than 5- HT alone.
Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
TLDR
Dolasetron provided well-tolerated, safe, and effective prophylaxis for post-operative nausea and vomiting with maximum effectiveness observed at a dose of 12.5 mg, with no additional benefit in complete response rates or nausea visual analogue scale scores at higher doses.
Efficacy, Dose‐Response, and Safety of Ondansetron in Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review of Randomized Placebo‐controlled Trials
TLDR
If the risk of PONV is very high, for every 100 patients receiving an adequate dose of ondansetron 20 patients will not vomit and three will have a headache who would not have had these adverse effects without the drug.
Treatment of Postoperative Nausea and Vomiting with Single Intravenous Doses of Dolasetron Mesylate: A Multicenter Trial
TLDR
In this study of 620 patients undergoing surgery, a 12.5-mg dose of intravenous dolasetron, a new serotonin-receptor blocker, was significantly more effective than placebo in treating established postoperative nausea and vomiting.
The Prophylactic Effect of Tropisetron on Epidural Morphine-Related Nausea and Vomiting: A Comparison of Dexamethasone with Saline
TLDR
It is concluded that IV tropisetron 5 mg did not prevent the occurrence of postoperative nausea and vomiting associated with epidural morphine, and IV dexamethasone 5 mg was effective for this purpose.
Single-Dose Prophylaxis for Postoperative Nausea and Vomiting after Major Abdominal Surgery: Ondansetron versus Droperidol
TLDR
Ondansetron was no better than droperidol, however, in reducing the incidence of vomiting or the need for antiemetic treatment during the first postoperative day, whether or not patients had a past history of PONV.
RETRACTED ARTICLE: Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis
TLDR
Granisetron is more effective than droperidol or metoclopramide in preventing PONV in female patients with a history of postoperative emesis, as well as other patients undergoing general anaesthesia for major gynaecological surgery.
A Comparison of Dexamethasone, Ondansetron, and Dexamethasone plus Ondansetron as Prophylactic Antiemetic and Antipruritic Therapy in Patients Receiving Intrathecal Morphine for Major Orthopedic Surgery
TLDR
It is concluded that the administration of dexamethasone 8 mg with ondansetron 4 mg has no added benefit compared with onranksetron 8 mg alone in the prophylaxis of PONV and pruritus.
...
...